As on Wednesday, PTC Therapeutics Inc (NASDAQ: PTCT) got off with the flyer as it spiked 5.98% to $71.77, before settling in for the price of $67.72 at the close. Taking a more long-term approach, PTCT posted a 52-week range of $35.95-$69.88.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -2.04%. Meanwhile, its Annual Earning per share during the time was -2.04%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 299.15%. This publicly-traded company’s shares outstanding now amounts to $79.93 million, simultaneously with a float of $76.03 million. The organization now has a market capitalization sitting at $5.44 billion. At the time of writing, stock’s 50-day Moving Average stood at $62.41, while the 200-day Moving Average is $52.34.
PTC Therapeutics Inc (PTCT) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. PTC Therapeutics Inc’s current insider ownership accounts for 4.29%, in contrast to 99.28% institutional ownership. According to the most recent insider trade that took place on Oct 30 ’25, this organization’s Director sold 15,666 shares at the rate of 69.50, making the entire transaction reach 1,088,787 in total value, affecting insider ownership by 6,666.
PTC Therapeutics Inc (PTCT) Earnings and Revenue Records
PTC Therapeutics Inc (NASDAQ: PTCT) Trading Performance Indicators
Let’s observe the current performance indicators for PTC Therapeutics Inc (PTCT). It’s Quick Ratio in the last reported quarter now stands at 2.26. Alongside those numbers, its PE Ratio stands at $8.38, and its Beta score is 0.49. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 3.06. Similarly, its price to free cash flow for trailing twelve months is now 7.71.
In the same vein, PTCT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 8.56, a figure that is expected to reach -0.41 in the next quarter, and analysts are predicting that it will be -0.97 at the market close of one year from today.
Technical Analysis of PTC Therapeutics Inc (PTCT)
Through scrutinizing the latest numbers posted by the [PTC Therapeutics Inc, PTCT], it can be observed that its last 5-days Average volume of 1.39 million was better the volume of 1.11 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 57.87% While, its Average True Range was 77.19.
Raw Stochastic average of PTC Therapeutics Inc (PTCT) in the period of the previous 100 days is set at 93.37%, which indicates a major rise in contrast to 76.40% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 2.41 that was higher than 2.08 volatility it exhibited in the past 100-days period.
